ASD ETF
Defiance Autism Impact ETF
ASD ETF Overview
ASD ETF (Defiance Autism Impact ETF) is managed by Defiance ETFs, LLC with $1.3M in net assets. ASD expense ratio is 0.79%, holding 40 positions across sectors including Health Care, Consumer Discretionary, Communication Services. Inception date: 2026-06-01.
ASD performance shows data across multiple time periods.. ASD dividend yield stands at 0.02%, paid quarterly.
ASD top holdings include Definium Therapeutics, Inc. Common Shares (4.0%), Neuren Pharmaceuticals Ltd (3.8%), Lifestance Health Group Inc (3.8%), Otsuka Holdings Co Ltd (3.2%), Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 (3.1%). Go to all ASD holdings, ASD sectors, or ASD dividends.
ASD can be compared against other funds. Use ASD overlap to find shared positions, or ASD vs another fund for a side-by-side view. ASD alternatives are available via the screener, along with tax-loss harvesting opportunities.